Investec has upgraded Star Health and Allied Insurance to 'Buy' with a target of ₹535 per share, citing clear recovery after a difficult FY24-FY25
The newly formed entity will operate in the pharmaceuticals sector and has been set up to expand the company's contract manufacturing and other pharmaceutical manufacturing operations
SAMHI Hotels reported a 573.08 per cent Y-o-Y rise in net profit to ₹1.75 crore for the quarter ended December 2025, compared with ₹0.26 crore in the corresponding quarter last year
According to data compiled by Bloomberg, about 8.4 per cent or 128.6 million shares changed hands in multiple block deals on the BSE. Buyers and sellers of the transactions were not known
Afcons Infra said it has received a termination notice from Societe Autoroutiere du Gabon (SAG) in relation to an EPC contract for National Road NR1 in Gabon
Aditya Infotech promoters Hari Khemka Business Family Trust and Rishi Khemka intended to sell up to 2 per cent equity aggregating to 23,55,961 equity shares
The US set a 126 per cent preliminary duty on solar imports from India, while the Trump administration set initial duties from 86 per cent to 143 per cent for Indonesia and 81 per cent for Laos
In Q4, Schaeffler India's consolidated net profit stood at ₹322.36 crore, compared to ₹237.28 crore, up 35.8 per cent.
Motilal Oswal estimates a 30 per cent compound annual growth rate (CAGR) in aggregate revenue of their EMS coverage companies over FY25-28.
Stocks to Watch today, February 25, 2026: Schaeffler India, Aditya Infotech, RVL are among few stocks that will be in focus
Stock Market LIVE on February 24, 2026:The Nifty MidCap and the Nifty SmallCap indices ended 0.32 per cent 0.55 per cent down, respectively
In the broader markets, the Nifty Midcap 100 and Nifty Smallcap 100 also traded in the red with a cut of 0.83 per cent and 1 per cent, respectively
Kotak Institutional Equities' favoured picks among NBFCs' include Bajaj Finance and Bajaj Finserv
The total mcap of BSE listed companies dropped by ₹4.73 trillion to ₹4,63,79,242 crore versus the previous session's mcap of ₹46,852,324.31 crore.
Indoco Remedies said it received final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Brivaracetam Oral Solution, 10 mg/mL
The stock rose after the company informed that its joint venture, MSIL-BIL (JV), has been declared L-1 (lowest bidder) for a ₹397-crore national highway project
Lineage Power Pvt. Ltd, a material subsidiary of the company, received a purchase order worth ₹158.71 crore, including GST, from Reliance Industries
The Nifty IT index has lost over 19 per cent in CY26 as compared to a nearly 2 per cent dip in the Nifty 50 index during this period
Over the past month, Morepen Laboratories has delivered a 34 per cent return, exceeding the Sensex's 2.2 per cent gain
Emkay Global has cut its FY26, FY27 and FY28 earnings estimates by 30 per cent, 13 per cent and 9 per cent, respectively